P2.16-30 Surgical Strategy for Clinical Stage IA Non-Small Cell Lung Cancer Patients With Risk Factors of Pathological Invasion and/or Metastasis

Journal of Thoracic Oncology- United States

doi 10.1016/j.jtho.2018.08.1505

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Choosing the Surgical Mortality Threshold for High Risk Patients With Stage Ia Non-Small Cell Lung Cancer: Insights From Decision Analysis

Respiratory Medicine

English

Prognostic Significance of Clinical/Pathological Stage IA Non-Small-Cell Lung Cancer Showing Partially Solid or Solid Tumours on Radiological Exam

Annals of Thoracic and Cardiovascular Surgery

Gastroenterology

Cardiovascular Medicine

Respiratory Medicine

English

P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.16-25 Impact of Diabetes Mellitus on Survival Outcome in Patients With Pathological Stage IA Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Incidence and Risk Factors for Bone Metastasis in Non-Small Cell Lung Cancer

Asian Pacific Journal of Cancer Prevention

English

Sialyl Lewis X as a Predictor of Skip N2 Metastasis in Clinical Stage IA Non-Small Cell Lung Cancer

World Journal of Surgical Oncology

English

Pathological Upstaging and Treatment Strategy of Clinical Stage I Small Cell Lung Cancer Following Surgery

Journal of Thoracic Disease

Respiratory Medicine

English

P2.16-44 Long-Term Outcome of Pulmonary Segmentectomy for C-Ia Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.16-33 Characteristics and Risk Factors of Recurrence After Segmentectomy in Patients With Clinical Stage I Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English